We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$120B
AUM Growth
+$1.51B
Cap. Flow
-$3.03B
Cap. Flow %
-2.53%
Top 10 Hldgs %
14.33%
Holding
3,102
New
125
Increased
894
Reduced
1,362
Closed
90

Top Sells

Rank Stock Value
1
LLL
L3 Technologies, Inc.
LLL
+$529M
2
RTX icon
RTX Corp
RTX
+$496M
3
CVS icon
CVS Health
CVS
+$406M
4
USB icon
US Bancorp
USB
+$395M
5
TWX
Time Warner Inc
TWX
+$279M

Sector Composition

Rank Sector Weight
1 Financials 16.51%
2 Technology 14.95%
3 Healthcare 13.16%
4 Industrials 10.42%
5 Consumer Discretionary 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MACK
2376
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$765K ﹤0.01%
23,819
THR
2377
DELISTED
Thermon Group Holdings
THR
$762K ﹤0.01%
39,920
BCRX icon
2378
BioCryst Pharmaceuticals
BCRX
$2.28B
$761K ﹤0.01%
120,220
-6,000
-5% -$31.2K
CEVA icon
2379
CEVA Inc
CEVA
$910M
$760K ﹤0.01%
22,650
JBSS icon
2380
John B. Sanfilippo & Son
JBSS
$967M
$760K ﹤0.01%
10,800
+3,500
+48% +$215K
MC icon
2381
Moelis & Co
MC
$4.97B
$760K ﹤0.01%
22,420
PTCT icon
2382
PTC Therapeutics
PTCT
$5.64B
$760K ﹤0.01%
69,650
TG icon
2383
Tredegar Corp
TG
$265M
$759K ﹤0.01%
31,619
+13,000
+70% +$273K
GLOG
2384
DELISTED
GASLOG LTD
GLOG
$758K ﹤0.01%
47,100
JRVR icon
2385
James River Group Holdings
JRVR
$208M
$752K ﹤0.01%
18,100
AXDX
2386
DELISTED
Accelerate Diagnostics
AXDX
$751K ﹤0.01%
3,621
+260
+8% +$61.7K
BFX
2387
DELISTED
BowFlex Inc.
BFX
$751K ﹤0.01%
40,600
CMA.WS
2388
DELISTED
Comerica Incorporated Ws
CMA.WS
$751K ﹤0.01%
19,387
WBKC
2389
DELISTED
Wolverine Bancorp, Inc.
WBKC
$751K ﹤0.01%
23,764
BPMC
2390
DELISTED
Blueprint Medicines
BPMC
$749K ﹤0.01%
26,700
HMC icon
2391
Honda
HMC
$39.1B
$748K ﹤0.01%
25,609
-65
-0.3% -$1.91K
ZG icon
2392
Zillow
ZG
$7.94B
$748K ﹤0.01%
20,511
-5,596
-21% -$196K
RBNC
2393
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$745K ﹤0.01%
34,620
-17,671
-34% -$356K
OCFC icon
2394
OceanFirst Financial
OCFC
$1.68B
$742K ﹤0.01%
24,700
+9,100
+58% +$212K
BCOM
2395
DELISTED
B Communications Ltd
BCOM
$742K ﹤0.01%
35,170
+5,810
+20% +$126K
CIG icon
2396
CEMIG Preferred Shares
CIG
$6.26B
$741K ﹤0.01%
+637,672
New +$809K
IWP icon
2397
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$740K ﹤0.01%
+15,192
New +$732K
EQM
2398
DELISTED
EQM Midstream Partners, LP
EQM
$739K ﹤0.01%
9,640
+1,208
+14% +$89.5K
CACQ
2399
DELISTED
Caesars Acquisition Company
CACQ
$739K ﹤0.01%
54,710
CART
2400
DELISTED
Carolina Trust BancShares
CART
$737K ﹤0.01%
115,196

Similar funds

AllianceBernstein's Q4 2016 Portfolio in Review

As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
  • AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
  • AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
  • AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
  • AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
  • AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
  • AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.

Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.